Electrostatic Attractive Self-Delivery of siRNA and Light-Induced Self-Escape for Synergistic Gene Therapy

Yuxin Yang1, Haijun Ning1, Tianping Xia1

  • 1State Key Laboratory of Fine Chemicals, Frontiers Science Center for Smart Materials Oriented Chemical Engineering, Dalian University of Technology, Dalian, 116024, China.

Insights

This study presents a novel carrier-free nanoparticle system for delivering small interfering RNA (siRNA) to target cancer cells. The system enhances siRNA delivery and release, improving therapeutic outcomes for cancer treatment.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Molecular Biology

Background:

  • Small interfering RNA (siRNA) is a promising therapeutic agent for gene silencing, particularly in cancer treatment.
  • Key challenges for siRNA therapeutics include efficient cellular delivery and overcoming endosomal/lysosomal entrapment.
  • Developing carrier-free delivery systems can simplify formulation and potentially improve therapeutic efficacy.

Purpose of the Study:

  • To develop a novel, carrier-free nanoparticle system for enhanced siRNA delivery and therapeutic application.
  • To investigate the potential of a cationic photosensitizer-siRNA conjugate for tumor targeting and photodynamic therapy.
  • To overcome the limitations of lysosomal entrapment for improved siRNA bioavailability.

Main Methods:

  • Grafting a cationic photosensitizer (NB-Br) onto polo-like kinase 1 (PLK1) siRNA to create an amphiphilic conjugate (siPLK1-NB).
  • Self-assembly of the conjugate into nanoparticles (siPLK1-NB NPs) through electrostatic attraction.
  • Evaluation of cellular uptake, tumor targeting, lysosomal escape via reactive oxygen species (ROS) generation upon photoactivation, and in vitro/in vivo anti-tumor efficacy.

Main Results:

  • siPLK1-NB NPs demonstrated rapid and efficient cell endocytosis and significant tumor targeting in vivo.
  • Photoactivated ROS generation facilitated lysosomal escape of siRNA from tumor cells.
  • The system effectively downregulated PLK1 expression, induced photodynamic killing, and inhibited tumor growth both in vitro and in vivo.
  • This represents the first reported carrier-free siRNA delivery system utilizing electrostatic attraction.

Conclusions:

  • The developed carrier-free siRNA-photosensitizer nanoparticles offer a promising strategy for cancer therapy.
  • This approach overcomes critical barriers in siRNA delivery, including cellular uptake and lysosomal escape.
  • The system integrates gene silencing with photodynamic therapy for enhanced anti-tumor effects.

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.6K